According to our knowledge, this is the first study investigating the relationship between NLR, which is an inflammatory marker, and DR and its severity. Our results suggest that while evaluating diabetes patients in terms of DR, higher NLR values may be a remarkable marker.
Objectives:To determine factors influencing compliance in patients with neovascular age-related macular degeneration (n-AMD) undergoing intravitreal anti-vascular endothelial growth factor (VEGF) therapy.Materials and Methods:The files of n-AMD patients recommended treatment with ranibizumab were reviewed retrospectively. The treatment regimen was 3 consecutive monthly injections followed by monthly follow-up with intravitreal injections as needed (pro re nata, PRN). Demographic and ocular characteristics were recorded. The patients were categorized into 2 groups: full compliance to treatment, or incomplete loading schedule and/or irregular maintenance treatment. All patients were interviewed by phone about factors affecting continuation of treatment.Results:Mean age of the 314 patients (160 female, 154 male) included in the study was 71.6±9.1 years. A total of 246 patients (78.3%) could complete 3 consecutive injections at 1-month intervals after the start of treatment; 57 patients (18.2%) did not attend monthly follow-up during the 1-year follow-up period following the 3 consecutive monthly injections. Overall, 39.8% of the patients were not able to fully comply with the ranibizumab treatment by PRN regimen for 1 year. Better visual acuity at baseline, smaller lesion size, living closer to the hospital, higher education and sociocultural level, and better financial status were determined as factors affecting patient compliance. The most frequent reasons to discontinue treatment were fear of injection, disbelief in the benefit of the treatment, financial limitations, continuation of treatment at another center, and comorbid systemic diseases.Conclusion:Patient compliance and success rates of anti-VEGF therapy may be increased by determining the factors affecting patient compliance and raising awareness about n-AMD among patients and their relatives.
Concentrations of heavy metals (Ag, Cd, Cr, Cu, Fe, Ni, Pb ve Zn) were measured in running water and in tissues (muscle, liver, gill, skin and gonads) of one commercially valuable fish species (Carasobarbus luteus) from the Orontes (Asi) River (Güzelburç region) in Hatay (Southeastern Turkey). Results for levels in water compared with national and international water quality guidelines were found at the highest concentrations in international criteria's WHO, EC and EPA, but Cd, Cu, Ni and Pb were found to exceed permissible level of drinking water in national criteria TSE-266 whereas Fe, Zn and Cr concentrations were within the permissible levels for drinking. The present study showed a significant seasonal variation (p < 0.05) in the concentration of the studied metals in the selected tissues, except gonads (p > 0.05), which showed seasonal variation of only Zn (p < 0.05). Maximum concentrations of Ag, Cd, Cr and Pb were detected in gonads followed by liver, gill, skin and muscle while maximum concentrations of Cu, Fe, Ni and Zn were detected in liver followed by other tissues. Concentrations of heavy metals in the muscle of C. luteus were below the permissible limit for human consumption, level of Cu being very close to the permissible limit. Consequently, continuous monitoring of heavy metal concentration in edible freshwater fish will be needed in Orontes River.
Introduction: Ecthyma gangrenosum is known as a characteristic lesion of Pseudomonas aeruginosa sepsis and is usually seen in immunocompromised patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.